dm+d
108914001
Medicine Compliance Aid Stability
NeotigasonTeva
Teva
Neotigason
Capsules 10mg, 25mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from light
20 October 2022
Lactation Safety Information
Topical psoriasis preparation / corticosteroid if appropriate
Very limited published evidence of safety
Long half-life increases risk of accumulation in breastfed infants
Risk to breastfed infant unknown but high risk of foetal damage if mother is not following contraception guidelines
15 September 2019